Reply to: Safety of dopamine agonists for treating restless legs syndrome.

Salminen, Aaro V; Allen, Richard P; Högl, Birgit; Inoue, Yuichi; Oertel, Wolfgang; Winkelman, John W; Trenkwalder, Claudia; Sampaio, Cristina; Winkelmann, Juliane

Salminen, Aaro V; Allen, Richard P; Högl, Birgit; Inoue, Yuichi; Oertel, Wolfgang; Winkelman, John W; Trenkwalder, Claudia; Sampaio, Cristina; Winkelmann, Juliane.

Afiliação

Salminen AV; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
Allen RP; Sleep Disorders Center, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States.
Högl B; Department of Neurology, Johns Hopkins University, Baltimore, Maryland, United States.
Inoue Y; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Oertel W; Japan Somnology Center, Neuropsychiatric Research Institute, Tokyo, Japan.
Winkelman JW; Department of Somnology, Tokyo Medical University, Tokyo, Japan.
Trenkwalder C; Department of Neurology, Philipps-Universität Marburg, Marburg, Germany.
Sampaio C; Harvard Medical School, Boston, Massachusetts, United States.
Winkelmann J; Departments of Psychiatry and Neurology, Massachusetts General Hospital, Boston, MA, United States.

Mov Disord ; 34(1): 150-151, 2019 01.

Article em En | MEDLINE | ID: mdl-30653723

Assuntos

Síndrome das Pernas Inquietas; Agonistas de Dopamina; Humanos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome das Pernas Inquietas Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google